Pyridoxine induces non-specific EEG alterations in infants with therapy resistant seizures

Seizure. 2007 Jul;16(5):459-64. doi: 10.1016/j.seizure.2007.02.008. Epub 2007 Apr 3.

Abstract

Purpose: In infants with frequent therapy resistant seizures (TRS-infants), clinical detection of pyridoxine-dependency (PD) or -responsiveness (PR) occurs by empirical intravenous (IV) pyridoxine administration during recording of the EEG. However, in undiagnosed TRS-infants it is still unclear to what extent EEG alterations by pyridoxine-IV are attributable to PD/PR or to non-specific responses. Before EEG alterations by pyridoxine-IV can be ascribed to PD/PR, these non-specific responses should be excluded first.

Methods: In 10 TRS-infants under 1 year of age, we determined the EEG effect by pyridoxine-IV on the EEG-recording.

Results: After pyridoxine-IV administration, our data indicate declined (10-15%; p<0.05) EEG-amplitudes and total power (magnitude/frequency-band) at frontal, central and centro-temporal electrodes.

Conclusion: In TRS-infants, pyridoxine-IV affects EEG-amplitude and -total power in a non-specific way, which does not identify PD/PR.

Publication types

  • Clinical Trial

MeSH terms

  • Electroencephalography / drug effects*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Pyridoxine / pharmacology*
  • Pyridoxine / therapeutic use
  • Seizures / drug therapy
  • Seizures / physiopathology*
  • Statistics, Nonparametric
  • Vitamin B Complex / pharmacology*
  • Vitamin B Complex / therapeutic use

Substances

  • Vitamin B Complex
  • Pyridoxine